Beam Therapeutics, Inc. (BEAM)

26.46 -1.26 (-4.55%) USD  |  NASDAQ  |  Jan 02, 13:29
More

Beam Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Repligen Corp. Upgrade